If you have POTS, you have almost certainly been offered medication. Beta blockers to slow the heart rate. Midodrine to raise blood pressure. Fludrocortisone to expand blood volume. Maybe ivabradine if the beta blocker side effects were too much. Your doctor saw a number that was too high and prescribed something to make it lower.
And maybe it helped. Genuinely helped. The pounding heart settled down. The anxiety-like sensations backed off enough that you could get through the day. That relief is real, and it matters. Nobody should feel bad about using whatever tools have kept them functional.
But you are still here. Still searching. Still symptomatic. The heart rate came down some, but the brain fog stayed. The fatigue stayed. The feeling of being unable to do normal things (grocery shopping, cooking dinner, standing long enough to have a conversation), that stayed too.
This is not an anti-medication argument. This is a mechanism argument. When you understand what the tachycardia is actually doing and why it exists, the logic of relying on medication alone starts to show its limits.
Why POTS Tachycardia Is a Compensation, Not the Disease
Your heart has an intrinsic firing rate of approximately 100 to 120 beats per minute, which is what it does on its own with no autonomic input. Jose and Collison established this in 1970 using complete pharmacological autonomic blockade in 432 healthy volunteers (Jose & Collison, Cardiovasc Res, 1970). At rest, the brain holds the rate down. When you stand and cerebral blood flow drops, the heart does the one thing it can do quickly: beat faster to push more blood upward against gravity.
That is not a malfunction. That is an intelligent compensation for a real problem. The heart rate is usually the compensation for the problem. The tachycardia is the most valuable tool the body has in response to whatever the underlying issue is.
Now think about what a beta blocker does. It takes away that tool. It clamps down the heart rate without fixing the reason the heart rate needed to be elevated. The brain was trying to maintain perfusion. You just told it to stop.
Where Each Medication Helps, and Where It Stops
This is not about which medication is "bad." Each one does something real. The question is whether what it does is enough.
| Medication | What It Does | What It Doesn't Reach |
|---|---|---|
| Beta blockers | Reduces heart rate, eases palpitations and anxiety-like symptoms | The cerebral perfusion drop that caused the heart rate to rise |
| Midodrine | Constricts blood vessels, raises standing blood pressure | The vestibulo-sympathetic reflex and brainstem coordination that should constrict them automatically |
| Fludrocortisone | Expands blood volume via sodium retention | The signal processing that should regulate volume distribution on its own |
| Ivabradine | Selectively slows heart rate without blood pressure effects | The cerebral blood flow deficit the heart rate was compensating for |
Each medication substitutes for a function the body should be performing on its own. The vestibulo-sympathetic reflex adjusts vascular tone within 50 to 100 milliseconds of a position change (Yates et al., Compr Physiol, 2014). Midodrine does it chemically, from the outside, with no dynamic adjustment. The renin-aldosterone system should regulate blood volume automatically. Fludrocortisone overrides that signal. In each case, the external override prevents the system from being challenged to regulate on its own, so it never recalibrates. The patient stays dependent on the medication, managing a symptom, while the regulation failure persists underneath.
Some patients feel weaker on beta blockers. More lethargic. Foggier. That can be the body telling you it needed that compensation, so it's not always a "side effect" in the traditional sense. When the heart rate was elevated, it was maintaining enough cerebral perfusion to keep you somewhat functional. Suppress that, and perfusion may drop further. Research bears this out: about 90% of 429 ME/CFS patients showed an abnormal drop in cerebral blood flow during tilt, including 82% of those whose heart rate and blood pressure looked normal (van Campen et al., Clin Neurophysiol Pract, 2020). If cerebral perfusion is already compromised, removing the heart rate compensation can make the brain's situation worse.
The ceiling: Medications bring the worst symptoms down from unbearable to tolerable. That is valuable. But tolerating a broken system is not the same as fixing it. If you have plateaued on medication (some improvement but not enough to reclaim normal function), the ceiling isn't you. It is the approach.
What the Head-to-Head Research Shows
A head-to-head comparison of a medication and exercise in POTS tells a clear story. Fu et al. gave 19 POTS patients 4 weeks of double-blind propranolol or placebo, followed by 3 months of exercise training. Training restored upright hemodynamics, improved renal-adrenal responsiveness and raised quality of life, while propranolol lowered standing heart rate but didn't improve quality of life (Fu et al., Hypertension, 2011). In the same group's earlier training study, 10 of 19 patients (53%) no longer met POTS criteria after 3 months (Fu et al., J Am Coll Cardiol, 2010).
A larger pragmatic trial confirmed the pattern: after 6 months, only 23% of the exercise group still met heart rate criteria for POTS vs 93% of controls (George et al., Heart Rhythm, 2021).
But there is an important nuance. Those exercise trials used a standardized cardiovascular protocol: the Levine or CHOP approach. One size fits all. Recumbent exercise progressing to upright over months. It works for some. In a community registry of 251 POTS patients, only 103 (41%) finished the 3-month program (George et al., Heart Rhythm, 2016). The dropout rate tells you the protocol does not match a lot of people's physiology. The exercise is not the problem. The dose is.
Salt, Fluids, and Compression Are Management
When people search for "POTS treatment without medication," the standard advice is: increase salt intake, drink more fluids, wear compression garments. These are not medications, true. But they are not treatment either. They are management strategies.
Salt and fluids expand blood volume. Compression garments reduce venous pooling in the legs. Both help in the short term. Neither one addresses why the regulation system failed to distribute blood effectively. Neither one restores the neurological coordination that should be handling this automatically. Management keeps you functional within the constraints of the dysfunction. Treatment removes the dysfunction so the constraints no longer exist.
There is a place for management, especially early on, while the regulation system is being rehabilitated. But management alone is a holding pattern, not a destination.
What Treatment Without Medication Actually Means
Real POTS treatment without medication is not about avoiding drugs for the sake of it. It is about addressing what medications cannot reach: the regulation failure itself.
The brain orchestrates the entire postural response through pathways at every level of the central nervous system. When you stand, the brainstem integrates data from vestibular organs, cervical proprioceptors, baroreceptors, and respiratory centers (among others) and coordinates a cardiovascular response in real time. The system has extraordinary depth. There are tracts, nuclei, and processing nodes involved at every level from the spinal cord to the cortex. Disruption at any point in that chain can produce the same downstream picture: symptoms that get labeled POTS.
The question is not "medication or no medication." It is: are you treating the compensation, or are you treating the regulation failure that made the compensation necessary?
Identifying the regulation failure requires measuring where it matters. Transcranial Doppler shows whether blood is reaching the brain during orthostatic challenge. Capnography reveals whether CO2-driven vasoconstriction is silently reducing cerebral perfusion. Del Pozzi et al. showed that the drop in cerebral blood flow precedes the hyperventilation by approximately 17 seconds (Del Pozzi et al., Hypertension, 2014), meaning the breathing changes are a consequence of the hemodynamic failure. Baker et al. confirmed in 2024 that reduced brain perfusion itself drives the respiratory and sympathetic activation (Baker et al., JACC Basic Transl Sci, 2024).
Breathing pattern disorders are not rare in this population. Reilly et al. found that 84% of 100 POTS patients had measurable dysfunctional breathing on formal assessment (Reilly et al., Auton Neurosci, 2020). And Stewart demonstrated that restoring CO2 levels via rebreathing in a hyperventilating POTS subgroup normalized heart rate, blood pressure, cardiac output, and systemic vascular resistance to control values (Stewart et al., JAHA, 2018). Fix the gas exchange, and the downstream numbers correct themselves.
How Neurological Rehabilitation Recalibrates the Regulation Failure
Once the specific regulation failure is identified, targeted rehabilitation challenges the circuits that have degraded. This is not a one-size-fits-all exercise prescription. Each component of rehabilitation targets a different input to the postural response, based on what the evaluation reveals.
Vestibular rehabilitation retrains the balance system's input to the brainstem, dosed to current capacity, because the nervous system has thresholds. Too much stimulus overwhelms a system that is already struggling. Oculomotor retraining drives activity in brainstem circuits that overlap with autonomic control centers. Cervical proprioceptive work restores accurate positional data flowing from the spine to the brainstem, and a randomized controlled trial confirmed that restoring cervical alignment produced significant normalization of autonomic function maintained at long-term follow-up (Moustafa et al., J Athl Train, 2021). Central respiratory integration retraining addresses hypocapnic vasoconstriction by restoring the brainstem's ability to regulate breathing automatically, which recalibrates the system so it automates properly again.
Exercise is dosed to cerebral blood flow data. When we have transcranial Doppler data, we know exactly how much hemodynamic stress the brain can currently tolerate. Right dose, right time, right progression. That's how patients who couldn't walk around the block begin rebuilding capacity without crashing.
The brain's capacity to change is not theoretical. The Nobel laureate Eric Kandel demonstrated that repeated, specific stimulation physically changes synaptic structure, growing new synaptic terminals that persist over time (Kandel, Science, 2001). That capacity does not disappear because you have POTS. When you challenge the specific circuits that have degraded (at the right intensity, targeting the right pathways), those circuits recalibrate. The postural response improves. Energy expenditure drops toward normal. The heart rate normalizes because the system no longer needs to compensate.
That is the difference between suppression and recalibration. Suppression manages a broken system. Recalibration rebuilds it.
Where Medication Fits
Not every patient needs to stop medication to begin rehabilitation. Some patients have severe enough symptoms that the pharmacological support (imperfect as it is) is keeping them functional enough to participate in treatment. Medications can serve as a bridge while the regulation system is being rebuilt.
The goal is not to rip away something that is helping. The goal is to restore enough regulation that the body no longer needs as much pharmacological support. Many patients continue their medications throughout rehabilitation, adjusting as function improves. The question at every stage is the same: is this medication supporting recovery, or is it substituting for a system that should be challenged to work on its own?
The question at every stage is the same: is this medication supporting recovery, or is it substituting for a system that should be challenged to work on its own?
The patients who benefit most from this approach are often the ones who have been on medications long enough to recognize the ceiling. The medications took the edge off, but life did not actually improve. Function did not return. The question "is this as good as it gets?" is the one that leads to looking for something different.
Dr. Keiser is a board-certified chiropractic neurologist (DC, DACNB, FABBIR), not a medical doctor (MD/DO). This content is for educational purposes and does not constitute medical advice. It is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult a qualified healthcare provider about your specific situation. Medication decisions should be made with your prescribing physician.
Key Takeaways
- POTS medications provide real symptomatic relief, but they manage the compensation without fixing the regulation failure that made the compensation necessary.
- In a head-to-head study, exercise beat propranolol on upright hemodynamics and quality of life, and 53% of trained patients in an earlier study no longer met POTS criteria. Propranolol did not improve quality of life.
- 84% of POTS patients have measurable dysfunctional breathing. Restoring CO2 levels normalized heart rate, blood pressure, and cardiac output in a hyperventilating subgroup.
- Rehabilitation targets the specific regulation failure through vestibular, oculomotor, proprioceptive, and respiratory inputs, each supported by primary research and each trainable through neuroplasticity.
- Medications can serve as a bridge while the system recalibrates. The goal is not to eliminate them prematurely but to rebuild the regulation so the body no longer depends on them.
Frequently Asked Questions
Can POTS be treated without medication?
POTS can be addressed through targeted neurological rehabilitation that identifies and treats the specific regulation failure driving symptoms. The tachycardia is a compensation for inadequate cerebral blood flow, rather than a primary cardiac problem. When the brain's coordination of the postural response is restored through vestibular rehabilitation, oculomotor retraining, proprioceptive work, central respiratory integration, and exercise dosed to cerebral blood flow data, the compensation resolves because it is no longer needed. Many patients continue medications during rehabilitation as a bridge while the system recalibrates.
Why don't POTS medications cure the condition?
POTS medications suppress compensatory responses without fixing the underlying regulation failure. Beta blockers reduce the heart rate the brain elevated to maintain cerebral perfusion. Midodrine constricts blood vessels without restoring the reflexes that should handle this automatically. Fludrocortisone expands blood volume without fixing the signal processing that should regulate volume. Each substitutes for a function the body should perform on its own. Because the system is never challenged to regulate independently, it never recalibrates, creating medication dependency while the root cause persists. In a 19-patient study, 3 months of exercise training improved quality of life and standing hemodynamics, while 4 weeks of propranolol lowered standing heart rate but did not improve quality of life (Fu et al. 2011).
What is the best non-drug treatment for POTS?
The most effective non-drug treatment for POTS identifies the specific mechanism driving each patient's regulation failure and targets it directly. This is different from generic advice like salt, fluids, and compression, which manage symptoms without addressing the cause. Mechanism-based evaluation uses transcranial Doppler, capnography, vestibular testing, and oculomotor assessment to find where the postural regulation is breaking down. Rehabilitation then targets those specific pathways through neuroplasticity-based training: the right inputs, at the right intensity, challenging the specific circuits that have degraded.
Should I stop my POTS medication before trying rehabilitation?
No. Medication decisions should be made with your prescribing physician, not unilaterally. Many patients continue their medications throughout neurological rehabilitation. Medications can serve as a bridge, providing stability while the regulation system is being rebuilt. The goal is to restore enough function that the body no longer requires as much pharmacological support. As rehabilitation progresses and autonomic regulation improves, medication adjustments can be discussed with your medical team.
Is exercise enough to treat POTS without medication?
Exercise training has the strongest evidence of any POTS intervention. In a 2010 training study, 10 of 19 POTS patients (53%) no longer met POTS criteria after 3 months (Fu et al. 2010), and in a later head-to-head study propranolol lowered heart rate but did not improve quality of life (Fu et al. 2011). However, standardized, one-size-fits-all exercise protocols lose a lot of people: in a community registry of 251 POTS patients, only 103 (41%) completed the 3-month program (George et al. 2016). When exercise is dosed to cerebral blood flow data and combined with targeted neurological rehabilitation addressing the specific regulation failure, patients can rebuild capacity without the crashes that cause dropout. Exercise is a critical component, but the dose and targeting matter as much as the exercise itself.
Get Your POTS & Dysautonomia Roadmap
A free guide to understanding what's actually happening in your brain, and what to do about it.
Get the Free Roadmap